- AMD Day 2014 - Saturday 5 July 2014
- Research team
- Our research programme
- Our research in the media
- Frequently asked questions (FAQ)
- Contact us
- Seminar series
- Join the team - opportunities and vacancies
- July 2013 -'Big leap' towards curing blindness in stem cell study
- April 2012 - Photoreceptor transplants restore vision in mice
Our latest blog posts
A profile of Prof. Robin Ali by MRC insight
Professor Robin Ali is an MRC-funded scientist working at the forefront of not one, but two, fields of regenerative medicine: gene and stem cell therapy. Katherine Nightingale caught up with Robin at UCL’s Institute of Ophthalmology to find out more about his work.
Restoring vision in night blindness: Mice point way to stem cell therapy
Professor Robin Ali and his team at the UCL Institute of Ophthalmology have announced the first demonstration that transplanted retinal rod cells can improve vision in mice with night-blindness, publishing the results of their study in the prestigious science journal Nature.
Prof. Robin Ali named as Visionary of the Quarter by European Vision Institute
Gene therapy is a powerful new approach for the treatment of eye disease. We aim to develop gene therapy not only for a number of relatively rare, but currently untreatable, inherited retinopathies, but also to develop more effective treatments for common ocular disorders involving neovascularisation and inflammation.
Interview with Prof. James Bainbridge by the NIHR
James Bainbridge is a Wellcome Advanced Fellow and consultant surgeon. He has an established programme of translational research, developing new molecular treatments for retinal disorders. He is principal investigator for the first clinical trial of gene therapy for inherited eye disease. He is leader of the diabetes research theme for the NIHR Biomedical Research Centre.
Page last modified on 03 jan 13 10:55